Inhibition of RXR and PPARγ ameliorates diet-induced obesity and type 2 diabetes
PPARγ is a ligand-activated transcription factor and functions as a heterodimer with a retinoid X receptor (RXR). Supraphysiological activation of PPARγ by thiazolidinediones can reduce insulin resistance and hyperglycemia in type 2 diabetes, but these drugs can also cause weight gain. Quite unexpec...
Gespeichert in:
| Veröffentlicht in: | J Clin Invest |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
American Society for Clinical Investigation
2001
|
| Schlagworte: | |
| Online-Zugang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC200951/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/11581301/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI12864 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|
